Subject matters | Details | Categories |
---|---|---|
Health
|
Food and Drug Act - An Act respecting food, drugs, cosmetics and therapeutic devices. Discussions relating to progressive licensing and the modernization of the Food & Drug Act.
|
Legislative Proposal, Bill or Resolution
|
Foreign Affairs, Health
|
Free trade treaty agreement as it relates to the North American Free Trade Agreement (NAFTA) and free trade negotiations as it relates to Columbia, India, and the European Union.
|
Policies or Program
|
Health, Industry
|
Intellectual Property - Changes to Patented Medicine (Notice of Compliance) (PMNOC) regulations - important regulations that can affect Eli Lilly's business.
|
Regulation
|
Health, Industry
|
Patent Act - An Act respecting patents of invention with regard to Intellectual Property Protection for pharmaceutical products - federal court decisions that have changed the disclosure requirements regarding the utility of an invention.
|
Legislative Proposal, Bill or Resolution
|
Health, Industry
|
Patented Medicine Notice of Compliance (PMNOC) Regulations - enforcement of Intellectual Property with respect to the Canadian pharmaceutical industry.
|
Regulation
|
Health, Industry
|
Patented Medicines Prices Review Board (PMPRB) proposed regulations, in regards to pharmaceutical pricing policy.
|
Policies or Program
|
Health, Industry, Science and Technology
|
The government's Science and Technology Strategy potential policies & programs pertaining to the biopharmaceutical industry.
|
Policies or Program
|
Address:
3650 Danforth Avenue
Toronto, ON M1N 2E8
Canada
Telephone number:
416-699-7222
Lauren Fischer, Vice President, Corporate Affairs
Eli Lilly Canada Inc. is not a coalition.
The activities of Eli Lilly Canada Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Beth Palmer | Public offices held
Firm: Earnscliffe Strategies